[1]Kojima N, Klausner JD. An update on the global epidemiology of syphilis[J]. Curr Epidemiol Rep,2018,5(1): 24-38.
[2]周亮,李杰,周松伟,等. ELISA联合甲苯胺红不加热血清试验检测梅毒螺旋体感染的效果分析[J]. 江苏大学学报(医学版),2009,19(5): 455-456.
[3]Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015[J]. MMWR Recomm Rep, 2015,64(RR3): 1-137.
[4]王千秋,范瑞强. 梅毒血清固定临床处理专家共识[J]. 中华皮肤科杂志,2015,48(11): 753-755.
[5]Stamm LV. Syphilis: Reemergence of an old foe[J]. Microb Cell, 2016,3(9): 363-370.
[6]Kim JI, Park JH, Choi JY, et al. Serologic response to treatment in human immunodeficiency virusnegative syphilis patients using automated serological tests: proposals for new guidelines[J]. Ann Dermatol, 2017,29(6): 768-775.
[7]Qin J,Yang T, Wang H, et al. Potential predictors for serofast state after treatment among hivnegative persons with syphilis in China: a systematic review and metaanalysis[J]. Iran J Public Health,2015,44(2): 155-169.
[8]Li X, He C, Liu C, et al. Expansion of NK cells from PBMCs using immobilized 41BBL and interleukin21[J]. Int J Oncol, 2015,47(1): 335-342.
[9]Kweon S, Phan MT, Chun S, et al. Expansion of human NK cells using K562 cells expressing OX40 ligand and short exposure to IL21[J]. Front Immunol,2019,10: 879.
[10]Seo H, Jeon I, Kim BS, et al. IL21mediated reversal of NK cell exhaustion facilitates antitumour immunity in MHC class Ⅰdeficient tumours[J]. Nat Commun,2017,8: 15776.
[11]Senju H, Kumagai A, Nakamura Y, et al. Effect of IL18 on the expansion and phenotype of human natural killer cells: application to cancer immunotherapy[J]. Int J Biol Sci, 2018,14(3): 331-340.
[12]Chaix J, Tessmer MS, Hoebe K, et al. Cutting edge: priming of NK cells by IL18[J]. J Immunol, 2008,181(3): 1627-1631.
[13]Frutoso M, Morisseau S, Tamzalit F, et al. Emergence of NK cell hyporesponsiveness after two IL15 stimulation cycles[J]. J Immunol,2018,201(2): 493-506.
[14]Lusty E, Poznanski SM, Kwofie K, et al. IL18/IL15/IL12 synergy induces elevated and prolonged IFNγ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation[J]. Mol Immunol,2017,88: 138-147.
[15]黄勇,崔雪娇,李双庚,等. T淋巴细胞亚群在梅毒血清固定患者外周血表达及对患者发病机制影响分析[J]. 中国性科学,2018,27(9): 94-97.
[16]谢奇朋,邢超,张琼,等. 梅毒血清固定患者外周血淋巴细胞亚群与快速血浆反应素效价的相关性[J]. 中华传染病杂志,2017,35(3): 165-168.
[17]梁服泉,朱秀兰,彭健华. 未治与血清固定梅毒患者外周血淋巴细胞亚群检测结果对比[J]. 吉林医学,2016,37(10): 2422-2423.
[18]刘铮,陈洁玲,梁小梅,等. 梅毒血清固定患者白细胞介素水平检测[J]. 实用皮肤病学杂志,2015,8(2): 102-103, 106.
[19]熊景红. 梅毒血清抵抗患者临床分析及免疫功能研究[J]. 中国卫生检验杂志,2015,25(1): 88-89.
[20]徐刚,郑健英,梅淑清,等. 梅毒血清固定患者检测外周血T细胞亚群、白细胞介素12、10与自然杀伤细胞水平的结果研究[J]. 实用医技杂志,2014,21(12): 1263-1265.
[21]谢海莉,赵进,李伟,等. 梅毒血清固定患者细胞免疫功能检测分析[J]. 中国皮肤性病学杂志,2013,27(1): 49-51.
[22]张春艳. 46例梅毒血清固定患者临床病因分析[J]. 检验医学与临床,2013,10(8): 991-992.
[23]关杨,杨帆,莫衍石,等. 54例梅毒血清固定患者临床分析及细胞免疫功能检测[J]. 中国热带医学,2013,13(10): 1266-1268.
[24]阮黎明,刘晓艳,蒋筱凌,等. 梅毒血清固定患者66例临床分析[J]. 浙江医学,2012,34(10): 786-788.
[25]凌昕,刘润秋,施辛,等. 梅毒血清固定与神经梅毒患者淋巴细胞亚群的检测[J]. 中国皮肤性病学杂志,2010,24(5): 418-420.
[26]刘金丽,胡白,赵政龙,等. 梅毒血清固定发病原因及相关影响因素分析[J]. 安徽医药,2010,14(6): 658-660.
[27]李军,王林娜,左亚刚,等. 梅毒血清抵抗患者临床分析及免疫功能研究[J]. 中华医学杂志,2009,89(12): 813-816.
[28]黄晶. 早期梅毒血清固定患者淋巴细胞的检测及意义[J]. 中国皮肤性病学杂志,2008,22(9): 546-547.
[29]包图雅,于娜沙,曾抗,等. 梅毒血清固定患者细胞免疫功能研究[J]. 实用预防医学,2006,13(2): 254-255.
[30]杨日东,蔡川川,田广南,等. 未治和血清固定梅毒患者外周血淋巴细胞亚群的比较研究[J]. 中国中西医结合皮肤性病学杂志,2005,4(1): 15-17.
[31]Rouce RH. More than memory: potential of adaptive natural killer cells[J]. Biol Blood Marrow Transplant, 2015, 21(9): 1534-1536.
[32]Del ZG, Marcenaro E, Vacca P, et al. Markers and function of human NK cells in normal and pathological conditions[J]. Cytometry B Clin Cytom, 2017,92(2): 100-114.
[33]Brady J, Carotta S, Thong RP, et al. The interactions of multiple cytokines control NK cell maturation[J]. J Immunol, 2010,185(11): 6679-6688.
[34]Pastuszczak M, Gozdzialska A, Jakiela B, et al. Robust proinflammatory immune response is associated with serological cure in patients with syphilis: an observational study[J].Sex Transm Infect, 2017,93(1): 11-14.
[35]Pastuszczak M, Jakiela B, WojasPelc A. Association of interleukin10 promoter polymorphisms with serofast state after syphilis treatment[J]. Sex Transm Infect, 2019,95(3): 163-168.
|